colesevelam bile acid sequestrant administered orally developed geltex pharmaceuticals later acquired genzyme marketed us daiichi sankyo brand name welchol elsewhere genzyme cholestagel canada marketed valeant lodalis colesevelam indicated adjunct diet exercise reduce elevated lowdensity lipoprotein cholesterol ldlc patients primary hyperlipidemia monotherapy improve glycemic control adults type diabetes including combination statin expanded use colesevelam adults type diabetes mellitus example drug repositioningcitation needed colesevelam one bileacid sequestrants along niacin statins three main types cholesterollowering agents statins considered firstline agents larger body evidence supporting statins ability prevent cardiovascular disease well prominent side effects two types including bloating constipation bileacid sequestrants skin flushing niacin side effects often lead low patient colesevelam used instead cholestyramine symptomatic chronic diarrhea due bile salt malabsorption bile acid diarrhea primary condition secondary crohns disease postcholecystectomy colesevelam modified polyallylamine made crosslinking polyallylamine epichlorohydrin modifying bromodecane bromide bromide ions replaced chloride ions material constituents polymer colesevelam shown subunits exist per se final product hydrogen chloride chloride colesevelam part class drugs known bile acid sequestrants colesevelam hydrochloride active pharmaceutical ingredient welchol nonabsorbed lipidlowering polymer binds bile acids intestine impeding reabsorption bile acid pool becomes depleted hepatic enzyme cholesterol upregulated increases conversion cholesterol bile acids causes increased demand cholesterol liver cells resulting dual effect increasing transcription activity cholesterol biosynthetic enzyme hmgcoa reductase increasing number hepatic ldl receptors compensatory effects result increased clearance ldlc blood resulting decreased serum ldlc levels serum tg levels may increase remain yet known colesevelam works help control blood sugar people type diabetes however clear drug works within digestive tract since absorbed rest bodycitation needed since colesevelam lower total ldl cholesterol levels along raising hdl taking may decrease ones risk developing certain health problems future previous clinical research studies indicate individuals taking mg mg colesevelam daily able combination colesevelam hmgcoa reductase inhibitor known commonly statin lower cholesterol controlled clinical studies involving approximately patients following adverse reactions reported patients treated colesevelam reporting common common uncommon rare distinction rarely including individual casescitation needed background incidence flatulence diarrhea patients controlled clinical trials higher placebo group constipation dyspepsia shown occur higher percentage patients received cholestagel compared placebo group side effects generally mild moderate severity application colesevelam combination statins unexpected frequent side effects httpsenwikipediaorgwikicolesevelam